We investigated whether myeloid precursor cells genetically modified to express TREM2 affect the disease course of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. The gene discussed is TREM2; the disease is experimental autoimmune encephalomyelitis.